Dual Roles of miR-10a-5p and miR-10b-5p as Tumor Suppressors and Oncogenes in Diverse Cancers
International Journal of Molecular Sciences · 06.01.2025 · 26 (1) · 415
DOI: 10.3390/ijms26010415 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.01.2025. Verfasst von Rajan Singh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Cell Biology, University of Nevada School of Medicine, Reno, NV 89557, USA. Hauptthemen laut MEDLINE: MicroRNAs, Neoplasms, Oncogenes, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: RosVivo Therapeutics Inc..
Abstract (Originalsprache)
Cancer is a complex genetic disorder characterized by abnormalities in both coding and regulatory non-coding RNAs. microRNAs (miRNAs) are key regulatory non-coding RNAs that modulate cancer development, functioning as both tumor suppressors and oncogenes. miRNAs play critical roles in cancer progression, influencing key processes such as initiation, promotion, and metastasis. They exert their effects by targeting tumor suppressor genes, thereby facilitating cancer progression, while also inhibiting oncogenes to prevent further disease advancement. The miR-10 family, particularly miR-10a-5p and miR-10b-5p (miR-10a/b-5p), is notably involved in cancer progression. Intriguingly, their functions can differ across different cancers, sometimes promoting and at other times suppressing tumor growth depending on the cancer type and target genes. This review explores the dual roles of miR-10a/b-5p as tumor-suppressive miRNAs (TSmiRs) or oncogenic miRNAs (oncomiRs) in various cancers by examining their molecular and cellular mechanisms and their impact on the tumor microenvironment. Furthermore, we discuss the potential of miR-10a/b-5p as therapeutic targets, emphasizing miRNA-based strategies for cancer treatment. The insights discussed in this review aim to advance our understanding of miR-10a/b-5p’s roles in tumor biology and their application in developing innovative cancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Cell Biology, University of Nevada School of Medicine, Reno, NV 89557, USA.
- Division of Endocrinology and Metabolism, Department of Medicine, Wonkwang University School of Medicine, Iksan 54538, Republic of Korea.
- RosVivo Therapeutics, Applied Research Facility, 1664 N. Virginia St., Reno, NV 89557, USA.
ORCID-Profile: Rajan Singh, Se Eun Ha, Tae Yang Yu, Seungil Ro
Förderung
- RosVivo Therapeutics Inc.
Zitieren
APA
Singh, R., Ha, S. E., Yu, T. Y., & Ro, S. (2025). Dual Roles of miR-10a-5p and miR-10b-5p as Tumor Suppressors and Oncogenes in Diverse Cancers. International Journal of Molecular Sciences, 26(1), 415. https://doi.org/10.3390/ijms26010415
Vancouver
Singh R, Ha SE, Yu TY, Ro S. Dual Roles of miR-10a-5p and miR-10b-5p as Tumor Suppressors and Oncogenes in Diverse Cancers. International Journal of Molecular Sciences. 2025;26(1):415. doi:10.3390/ijms26010415
BibTeX
@article{Singh2025,
author = {Singh, Rajan and Ha, Se Eun and Yu, Tae Yang and Ro, Seungil},
title = {Dual Roles of miR-10a-5p and miR-10b-5p as Tumor Suppressors and Oncogenes in Diverse Cancers},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {1},
pages = {415},
doi = {10.3390/ijms26010415}
}
EUVIMED